(Total Views: 197)
Posted On: 02/25/2022 8:25:26 AM
Post# of 250673

$STAB News February 15, 2022
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html

